Describes Emil Freireich's research into drugs to treat acute lymphoblastic leukemia (ALL) in the nineteen-fifties and sixties.
NEWYORKER: The Treatment
2.
Working with a group that included Tom Frei, of the National Cancer Institute, and James Holland, of the Roswell Park Cancer Institute, Freireich started treating ALL patients with a combination of drugs.